Review



b atcc 43300  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC b atcc 43300
    B Atcc 43300, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 35800 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/b atcc 43300/product/ATCC
    Average 99 stars, based on 35800 article reviews
    b atcc 43300 - by Bioz Stars, 2026-03
    99/100 stars

    Images



    Similar Products

    99
    ATCC b atcc 43300
    B Atcc 43300, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/b atcc 43300/product/ATCC
    Average 99 stars, based on 1 article reviews
    b atcc 43300 - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    ATCC mrsa acinetobacter enterobacter escherichia atcc baumannii cloacae coli 43300 b 65371 nrrl b 425 k12 mbic90
    Mrsa Acinetobacter Enterobacter Escherichia Atcc Baumannii Cloacae Coli 43300 B 65371 Nrrl B 425 K12 Mbic90, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mrsa acinetobacter enterobacter escherichia atcc baumannii cloacae coli 43300 b 65371 nrrl b 425 k12 mbic90/product/ATCC
    Average 99 stars, based on 1 article reviews
    mrsa acinetobacter enterobacter escherichia atcc baumannii cloacae coli 43300 b 65371 nrrl b 425 k12 mbic90 - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    ATCC su rfa ce d la bn b staphylococcus aureus atcc 43300
    Su Rfa Ce D La Bn B Staphylococcus Aureus Atcc 43300, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/su rfa ce d la bn b staphylococcus aureus atcc 43300/product/ATCC
    Average 99 stars, based on 1 article reviews
    su rfa ce d la bn b staphylococcus aureus atcc 43300 - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    ATCC agmatine 15n arginine atcc 25922 atcc baa 196 mg1665 atcc 25923 atcc 43300 n6 methyladenine b c nature communications
    Agmatine 15n Arginine Atcc 25922 Atcc Baa 196 Mg1665 Atcc 25923 Atcc 43300 N6 Methyladenine B C Nature Communications, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/agmatine 15n arginine atcc 25922 atcc baa 196 mg1665 atcc 25923 atcc 43300 n6 methyladenine b c nature communications/product/ATCC
    Average 99 stars, based on 1 article reviews
    agmatine 15n arginine atcc 25922 atcc baa 196 mg1665 atcc 25923 atcc 43300 n6 methyladenine b c nature communications - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    ATCC b s aureus atcc 43300
    A Evolution of resistant mutants of SMJ-2 (blue) and ciprofloxacin (brown) in cation-adjusted broth on S. aureus ATCC 29213, B S. aureus ATCC 43300, and ( C ) B. subtilis MTCC 121. Cells were passaged every 24 h. D , E Time-kill kinetic assay of SMJ-2 and SMJ-4 on S. aureus ATCC-MRSA-43300 in logarithmic and stationary phase respectively, the concentration of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin at 10 × MIC. MIC of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin were 2, 4, 1, 2, and 64 µg mL −1 respectively; (L.O.D. = Limit of Detection), F Photographic representation of SMJ-2, SMJ-4, vancomycin and linezolid treatment on S. aureus ATCC-MRSA-43300 in logarithmic phase, G Oxacillin treatment to S. aureus ATCC-29213 form persister cells, H Persister killing assay in the presence of SMJ-2 at 5 × MIC, 10 × MIC, and 20 × MIC and linezolid was used as positive control at 10 × MIC, and 20 × MIC. Experiments ( A – C ) represent two individual repeats ( n = 2 biologically independent experiments), D , E , G , and H represent three individual repeats ( n = 3 biologically independent samples), and the results correspond to average ± standard deviation.
    B S Aureus Atcc 43300, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/b s aureus atcc 43300/product/ATCC
    Average 99 stars, based on 1 article reviews
    b s aureus atcc 43300 - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    ATCC staphylococcus aureus atcc 43300 b 6 6 staphylococcus hominis atcc
    A Evolution of resistant mutants of SMJ-2 (blue) and ciprofloxacin (brown) in cation-adjusted broth on S. aureus ATCC 29213, B S. aureus ATCC 43300, and ( C ) B. subtilis MTCC 121. Cells were passaged every 24 h. D , E Time-kill kinetic assay of SMJ-2 and SMJ-4 on S. aureus ATCC-MRSA-43300 in logarithmic and stationary phase respectively, the concentration of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin at 10 × MIC. MIC of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin were 2, 4, 1, 2, and 64 µg mL −1 respectively; (L.O.D. = Limit of Detection), F Photographic representation of SMJ-2, SMJ-4, vancomycin and linezolid treatment on S. aureus ATCC-MRSA-43300 in logarithmic phase, G Oxacillin treatment to S. aureus ATCC-29213 form persister cells, H Persister killing assay in the presence of SMJ-2 at 5 × MIC, 10 × MIC, and 20 × MIC and linezolid was used as positive control at 10 × MIC, and 20 × MIC. Experiments ( A – C ) represent two individual repeats ( n = 2 biologically independent experiments), D , E , G , and H represent three individual repeats ( n = 3 biologically independent samples), and the results correspond to average ± standard deviation.
    Staphylococcus Aureus Atcc 43300 B 6 6 Staphylococcus Hominis Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/staphylococcus aureus atcc 43300 b 6 6 staphylococcus hominis atcc/product/ATCC
    Average 99 stars, based on 1 article reviews
    staphylococcus aureus atcc 43300 b 6 6 staphylococcus hominis atcc - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    ATCC b mrsa atcc 43300
    A Evolution of resistant mutants of SMJ-2 (blue) and ciprofloxacin (brown) in cation-adjusted broth on S. aureus ATCC 29213, B S. aureus ATCC 43300, and ( C ) B. subtilis MTCC 121. Cells were passaged every 24 h. D , E Time-kill kinetic assay of SMJ-2 and SMJ-4 on S. aureus ATCC-MRSA-43300 in logarithmic and stationary phase respectively, the concentration of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin at 10 × MIC. MIC of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin were 2, 4, 1, 2, and 64 µg mL −1 respectively; (L.O.D. = Limit of Detection), F Photographic representation of SMJ-2, SMJ-4, vancomycin and linezolid treatment on S. aureus ATCC-MRSA-43300 in logarithmic phase, G Oxacillin treatment to S. aureus ATCC-29213 form persister cells, H Persister killing assay in the presence of SMJ-2 at 5 × MIC, 10 × MIC, and 20 × MIC and linezolid was used as positive control at 10 × MIC, and 20 × MIC. Experiments ( A – C ) represent two individual repeats ( n = 2 biologically independent experiments), D , E , G , and H represent three individual repeats ( n = 3 biologically independent samples), and the results correspond to average ± standard deviation.
    B Mrsa Atcc 43300, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/b mrsa atcc 43300/product/ATCC
    Average 99 stars, based on 1 article reviews
    b mrsa atcc 43300 - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    ATCC iliciclin b against s aureus atcc 43300
    A Evolution of resistant mutants of SMJ-2 (blue) and ciprofloxacin (brown) in cation-adjusted broth on S. aureus ATCC 29213, B S. aureus ATCC 43300, and ( C ) B. subtilis MTCC 121. Cells were passaged every 24 h. D , E Time-kill kinetic assay of SMJ-2 and SMJ-4 on S. aureus ATCC-MRSA-43300 in logarithmic and stationary phase respectively, the concentration of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin at 10 × MIC. MIC of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin were 2, 4, 1, 2, and 64 µg mL −1 respectively; (L.O.D. = Limit of Detection), F Photographic representation of SMJ-2, SMJ-4, vancomycin and linezolid treatment on S. aureus ATCC-MRSA-43300 in logarithmic phase, G Oxacillin treatment to S. aureus ATCC-29213 form persister cells, H Persister killing assay in the presence of SMJ-2 at 5 × MIC, 10 × MIC, and 20 × MIC and linezolid was used as positive control at 10 × MIC, and 20 × MIC. Experiments ( A – C ) represent two individual repeats ( n = 2 biologically independent experiments), D , E , G , and H represent three individual repeats ( n = 3 biologically independent samples), and the results correspond to average ± standard deviation.
    Iliciclin B Against S Aureus Atcc 43300, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/iliciclin b against s aureus atcc 43300/product/ATCC
    Average 99 stars, based on 1 article reviews
    iliciclin b against s aureus atcc 43300 - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    ATCC b mrsa atcc 43300 with vancomycin
    A Evolution of resistant mutants of SMJ-2 (blue) and ciprofloxacin (brown) in cation-adjusted broth on S. aureus ATCC 29213, B S. aureus ATCC 43300, and ( C ) B. subtilis MTCC 121. Cells were passaged every 24 h. D , E Time-kill kinetic assay of SMJ-2 and SMJ-4 on S. aureus ATCC-MRSA-43300 in logarithmic and stationary phase respectively, the concentration of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin at 10 × MIC. MIC of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin were 2, 4, 1, 2, and 64 µg mL −1 respectively; (L.O.D. = Limit of Detection), F Photographic representation of SMJ-2, SMJ-4, vancomycin and linezolid treatment on S. aureus ATCC-MRSA-43300 in logarithmic phase, G Oxacillin treatment to S. aureus ATCC-29213 form persister cells, H Persister killing assay in the presence of SMJ-2 at 5 × MIC, 10 × MIC, and 20 × MIC and linezolid was used as positive control at 10 × MIC, and 20 × MIC. Experiments ( A – C ) represent two individual repeats ( n = 2 biologically independent experiments), D , E , G , and H represent three individual repeats ( n = 3 biologically independent samples), and the results correspond to average ± standard deviation.
    B Mrsa Atcc 43300 With Vancomycin, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/b mrsa atcc 43300 with vancomycin/product/ATCC
    Average 99 stars, based on 1 article reviews
    b mrsa atcc 43300 with vancomycin - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    99
    ATCC b s atcc 6633 b c atcc 11778 e f atcc 29212 s a atcc 6538 s a atcc 43300 e coli atcc 8739 s typhi
    A Evolution of resistant mutants of SMJ-2 (blue) and ciprofloxacin (brown) in cation-adjusted broth on S. aureus ATCC 29213, B S. aureus ATCC 43300, and ( C ) B. subtilis MTCC 121. Cells were passaged every 24 h. D , E Time-kill kinetic assay of SMJ-2 and SMJ-4 on S. aureus ATCC-MRSA-43300 in logarithmic and stationary phase respectively, the concentration of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin at 10 × MIC. MIC of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin were 2, 4, 1, 2, and 64 µg mL −1 respectively; (L.O.D. = Limit of Detection), F Photographic representation of SMJ-2, SMJ-4, vancomycin and linezolid treatment on S. aureus ATCC-MRSA-43300 in logarithmic phase, G Oxacillin treatment to S. aureus ATCC-29213 form persister cells, H Persister killing assay in the presence of SMJ-2 at 5 × MIC, 10 × MIC, and 20 × MIC and linezolid was used as positive control at 10 × MIC, and 20 × MIC. Experiments ( A – C ) represent two individual repeats ( n = 2 biologically independent experiments), D , E , G , and H represent three individual repeats ( n = 3 biologically independent samples), and the results correspond to average ± standard deviation.
    B S Atcc 6633 B C Atcc 11778 E F Atcc 29212 S A Atcc 6538 S A Atcc 43300 E Coli Atcc 8739 S Typhi, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/b s atcc 6633 b c atcc 11778 e f atcc 29212 s a atcc 6538 s a atcc 43300 e coli atcc 8739 s typhi/product/ATCC
    Average 99 stars, based on 1 article reviews
    b s atcc 6633 b c atcc 11778 e f atcc 29212 s a atcc 6538 s a atcc 43300 e coli atcc 8739 s typhi - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    Image Search Results


    A Evolution of resistant mutants of SMJ-2 (blue) and ciprofloxacin (brown) in cation-adjusted broth on S. aureus ATCC 29213, B S. aureus ATCC 43300, and ( C ) B. subtilis MTCC 121. Cells were passaged every 24 h. D , E Time-kill kinetic assay of SMJ-2 and SMJ-4 on S. aureus ATCC-MRSA-43300 in logarithmic and stationary phase respectively, the concentration of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin at 10 × MIC. MIC of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin were 2, 4, 1, 2, and 64 µg mL −1 respectively; (L.O.D. = Limit of Detection), F Photographic representation of SMJ-2, SMJ-4, vancomycin and linezolid treatment on S. aureus ATCC-MRSA-43300 in logarithmic phase, G Oxacillin treatment to S. aureus ATCC-29213 form persister cells, H Persister killing assay in the presence of SMJ-2 at 5 × MIC, 10 × MIC, and 20 × MIC and linezolid was used as positive control at 10 × MIC, and 20 × MIC. Experiments ( A – C ) represent two individual repeats ( n = 2 biologically independent experiments), D , E , G , and H represent three individual repeats ( n = 3 biologically independent samples), and the results correspond to average ± standard deviation.

    Journal: Communications Biology

    Article Title: Synthetic indole derivatives as an antibacterial agent inhibiting respiratory metabolism of multidrug-resistant gram-positive bacteria

    doi: 10.1038/s42003-024-06996-8

    Figure Lengend Snippet: A Evolution of resistant mutants of SMJ-2 (blue) and ciprofloxacin (brown) in cation-adjusted broth on S. aureus ATCC 29213, B S. aureus ATCC 43300, and ( C ) B. subtilis MTCC 121. Cells were passaged every 24 h. D , E Time-kill kinetic assay of SMJ-2 and SMJ-4 on S. aureus ATCC-MRSA-43300 in logarithmic and stationary phase respectively, the concentration of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin at 10 × MIC. MIC of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin were 2, 4, 1, 2, and 64 µg mL −1 respectively; (L.O.D. = Limit of Detection), F Photographic representation of SMJ-2, SMJ-4, vancomycin and linezolid treatment on S. aureus ATCC-MRSA-43300 in logarithmic phase, G Oxacillin treatment to S. aureus ATCC-29213 form persister cells, H Persister killing assay in the presence of SMJ-2 at 5 × MIC, 10 × MIC, and 20 × MIC and linezolid was used as positive control at 10 × MIC, and 20 × MIC. Experiments ( A – C ) represent two individual repeats ( n = 2 biologically independent experiments), D , E , G , and H represent three individual repeats ( n = 3 biologically independent samples), and the results correspond to average ± standard deviation.

    Article Snippet: A Evolution of resistant mutants of SMJ-2 (blue) and ciprofloxacin (brown) in cation-adjusted broth on S. aureus ATCC 29213, B S. aureus ATCC 43300, and ( C ) B. subtilis MTCC 121.

    Techniques: Kinetic Assay, Concentration Assay, Positive Control, Standard Deviation